| Zugriffe | |
|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 144 |
| Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | |
|---|---|---|---|---|---|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 3 | 2 | 11 | 27 | 12 | 2 | 2 |
| Zugriffe | |
|---|---|
| 2023_Kreye_etal.pdf | 51 |
